EXCITING TRIAL RESULTS SIGNAL HUGE OPPORTUNITY FOR INVESTORS IN MALE PATTERN BALDNESS — NICE PROFITS IN VERADERMICS INC (MANE)
By Nigam Arora
MANE is long from $84.88. It is trading up 13% today at $122.69 as of this writing.
Huge Opportunity
There is a large market opportunity. Approximately 50 million American men experience pattern hair loss. If approved, VDPHL01 could become the first new FDA approved oral treatment for pattern hair loss in nearly 30 years.
Trial Results
MANE just announced positive Phase 3 results for VDPHL01, its oral treatment for male pattern hair loss.
Here are the key points:
- All primary and secondary endpoints were met with high statistical significance in a Phase 3 trial involving 536 men.
- After six months, hair counts increased by 28.6 hairs/cm² with once daily dosing and 36.4 hairs/cm² with twice daily dosing, compared with 6.6 hairs/cm² for placebo.
October 20, 2026